共 50 条
- [22] Evaluation of the effect of new formulation, food, or a proton pump inhibitor on the relative bioavailability of the smoothened inhibitor glasdegib (PF-04449913) in healthy volunteers Cancer Chemotherapy and Pharmacology, 2017, 80 : 1249 - 1260
- [25] Gastric Biopsy Results From Patients Treated With Dexlansoprazole MR, a Proton Pump Inhibitor with a Dual Delayed Release Formulation AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S5 - S5
- [28] Effects of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor, on Plasma Gastrin Levels in Healthy Subjects JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (04): : 444 - 454
- [29] Lack of Electrocardiographic Effect of Dexlansoprazole MR, a Novel Modified-Release Formulation of the Proton Pump Inhibitor Dexlansoprazole, in Healthy Participants JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (12): : 1447 - 1455